Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 1623075)

Published in Clin Infect Dis on June 01, 1992

Authors

L L Dever1, J W Martin, B Seaworth, J H Jorgensen

Author Affiliations

1: Department of Medicine, University of Texas Health Sciences Center, San Antonio 78284.

Articles citing this

Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev (1996) 10.34

Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev (1996) 2.04

Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev (2011) 1.13

Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B). Infect Immun (1996) 1.12

Optimal detection and identification of Mycobacterium haemophilum in specimens from pediatric patients with cervical lymphadenopathy. J Clin Microbiol (1999) 1.08

Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother (1993) 0.98

Mycobacterium haemophilum osteomyelitis: case report and review of the literature. BMC Infect Dis (2006) 0.91

Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum. J Clin Microbiol (1994) 0.90

Direct identification of Mycobacterium haemophilum in skin lesions of immunocompromised patients by PCR-restriction endonuclease analysis. J Clin Microbiol (2004) 0.82

Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol (2010) 0.80

Treatment of Mycobacterium haemophilum infection in a murine model with clarithromycin, rifabutin, and ciprofloxacin. Antimicrob Agents Chemother (1995) 0.79

Articles by these authors

(truncated to the top 100)

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05

Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88

Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2003) 4.31

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 3.40

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09

Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02

Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis (1995) 2.80

Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis (1986) 2.77

Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 2.71

Comparative evaluation of the Limulus assay and the direct Gram stain for detection of significant bacteriuria. Am J Clin Pathol (1975) 2.69

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57

Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40

Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res (2000) 2.34

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29

Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium. Eur J Clin Microbiol Infect Dis (1990) 2.12

Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother (1983) 2.11

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med (1993) 2.10

Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay. Appl Microbiol (1973) 2.09

In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.06

Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 2.03

Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97

Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother (1997) 1.95

Xenorhabdus luminescens (DNA hybridization group 5) from human clinical specimens. J Clin Microbiol (1989) 1.88

Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med (1984) 1.88

Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1990) 1.87

Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob Agents Chemother (1981) 1.77

Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study. J Clin Microbiol (1999) 1.76

In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. Eur J Clin Microbiol (1987) 1.76

In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75

Identification of coagulase-negative staphylococci with the API STAPH-IDENT system. J Clin Microbiol (1983) 1.70

Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70

Mycoplasma pneumoniae pneumonia. Chest (1989) 1.67

In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59

Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.59

Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med (1983) 1.56

Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci. J Clin Microbiol (1982) 1.54

Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis (1992) 1.53

Back pain in industry. A prospective survey. Spine (Phila Pa 1976) (1981) 1.53

Comparison of automated and rapid manual methods for the same-day identification of Enterobacteriaceae. Am J Clin Pathol (1983) 1.53

Rapid detection of contaminated intravenous fluids using the Limulus in vitro endotoxin assay. Appl Microbiol (1973) 1.52

Simplified bioassay method for measurement of flucytosine or ketoconazole. J Clin Microbiol (1985) 1.52

Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay. Appl Microbiol (1973) 1.51

Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother (2008) 1.51

Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay. J Clin Microbiol (1978) 1.51

Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47

Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. J Clin Microbiol (1988) 1.44

Atmospheric lifetime of fluorotelomer alcohols. Environ Sci Technol (2003) 1.42

In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 1.40

Measurements of ultracold-neutron lifetimes in solid deuterium. Phys Rev Lett (2002) 1.38

Microdilution technique for antimicrobial susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 1.37

Evaluation of the automicrobic system gram-positive identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.35

High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med (1983) 1.33

Cigarette smoking, physical fitness, and injuries in infantry soldiers. Am J Prev Med (1994) 1.30

Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2000) 1.28

Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25

Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (1993) 1.23

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20

Rapid detection of bacterial endotoxins in drinking water and renovated wastewater. Appl Environ Microbiol (1976) 1.20

Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.20

Methylobacterium mesophilicum infection: case report and literature review of an unusual opportunistic pathogen. Clin Infect Dis (2000) 1.19

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst (1997) 1.19

Morphometric abnormalities in brains of great blue heron hatchlings exposed in the wild to PCDDs. Environ Health Perspect (1995) 1.18

Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15

Sexually transmitted diseases in prison women. Pa Med (1988) 1.14

Characterization of Staphylococcus aureus in a pediatric burn unit. Appl Microbiol (1973) 1.14

Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae. Diagn Microbiol Infect Dis (1984) 1.13

Oral complications associated with cancer therapy. An M. D. Anderson Cancer Center experience. J Clin Periodontol (1990) 1.08

Measurement of bound and free endotoxin by the Limulus assay. Proc Soc Exp Biol Med (1974) 1.06

Collaborative evaluation of the Abbott Avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli. J Clin Microbiol (1984) 1.05

Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol (1992) 1.04

Standardized disk-diffusion susceptibility test for Haemophilus influenzae. Am J Clin Pathol (1977) 1.04

Cranial implant modification. J Prosthet Dent (1984) 1.03

Experience with Barton button and peristomal breathing valve attachments for hands-free tracheoesophageal speech. Head Neck (2000) 1.03

Ketoconazole therapy of murine cryptococcal meningitis. Am Rev Respir Dis (1982) 1.03

Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis (2001) 1.00

Technique for fabricating a mirror-image prosthetic ear. J Prosthet Dent (1996) 1.00

Reproducibility of disc susceptibility tests with Haemophilus influenzae. J Antimicrob Chemother (1991) 1.00

Bacteriophages and endotoxin in licensed live-virus vaccines. J Infect Dis (1975) 1.00

Computerization of a hospital clinical microbiology laboratory. Am J Clin Pathol (1978) 0.99

Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med (1995) 0.99

Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods. J Clin Microbiol (1984) 0.99

Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. Clin Infect Dis (2001) 0.99

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. J Clin Microbiol (1992) 0.98

Rapid detection of significant bacteriuria by use of an automated Limulus amoebocyte lysate assay. J Clin Microbiol (1982) 0.98

Rapid identification of group D streptococci with the API 20S system. J Clin Microbiol (1983) 0.98

Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis (2000) 0.98

A32390A, a new biologically active metabolite. II. Isolation and structure. J Antibiot (Tokyo) (1978) 0.98

Hollow obturator with removable lid. J Prosthet Dent (1985) 0.97

Modified technique for preparing a polyurethane lining for facial prostheses. J Prosthet Dent (1992) 0.97

Rapid determination of novobiocin resistance of coagulase-negative staphylococci with the MS-2 system. J Clin Microbiol (1983) 0.97

Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy. Am J Med (1977) 0.95

In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites. Antimicrob Agents Chemother (1996) 0.95

Rehabilitation of a midface defect with reconstructive surgery and facial prosthetics: a case report. Int J Oral Maxillofac Implants (1996) 0.95

Practical anaerobic broth-disk elution susceptibility test. Antimicrob Agents Chemother (1980) 0.95

Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents. Antimicrob Agents Chemother (2005) 0.94

First determination of the weak charge of the proton. Phys Rev Lett (2013) 0.94

The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin. J Infect Dis (1995) 0.93

Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother (1985) 0.93

Automation of the Limulus amoebocyte lysate test by using the Abbott MS-2 microbiology system. Appl Environ Microbiol (1981) 0.92